SCHEMBL6532438

SCHEMBL6532438

CCOc1ccc2ccccc2c1C(C)N

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.46
NCEH1 Q6PIU2 1/20 0.41
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 1/20 0.41
DHFR P00374 1/20 0.41
MAPK1 P28482 2/20 0.40
HPGD P15428 1/20 0.40
S1PR1 P21453 1/20 0.40
S1PR3 Q99500 1/20 0.40
LMNA P02545 2/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TLR8 Q9NR97 1/20 0.40
MAPT P10636 1/20 0.40
GAA P10253 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10136521 0.87 NCEH1 (0.54) ALOX5NCEH1ALDH1A1KDM4EDHFR
SCHEMBL15750908 0.84 ALOX5 (0.46) ALOX5NCEH1ALDH1A1KDM4EMAPK1
SCHEMBL809207 0.81 ALOX5 (0.44) ALOX5NCEH1ALDH1A1KDM4EDHFR
SCHEMBL808973 0.81 ALOX5 (0.44) ALOX5NCEH1ALDH1A1KDM4EDHFR
Iodide SCHEMBL25290235 0.80 MAPT (0.55) NCEH1ALDH1A1KDM4EMAPK1HPGD
SCHEMBL15750787 0.79 ALOX5 (0.45) ALOX5NCEH1ALDH1A1KDM4EMAPK1
SCHEMBL19036424 0.79 ALOX5 (0.40) ALOX5ALDH1A1KDM4EDHFRMAPK1
SCHEMBL1807920 0.76 NCEH1 (0.53) ALOX5NCEH1ALDH1A1KDM4EDHFR
SCHEMBL5950064 0.76 L3MBTL1 (0.45) ALOX5NCEH1ALDH1A1KDM4EMAPK1
SCHEMBL2045141 0.75 ALOX5 (0.65) ALOX5ALDH1A1KDM4EDHFRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575951-A1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY Affinium Pharmaceuticals, Inc. (CA) 2005-09-21 EP disclosed
WO-2004052890-A1 HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY AFFINIUM PHARMACEUTICALS, INC. (CA) 2004-06-24 WO disclosed